SIRNAOMICS-B (02257) Chairman Pan Honghui Increases Holdings by 100,000 Shares

Stock News

2025/12/08

SIRNAOMICS-B (02257) announced that Dr. Pan Honghui, the company's Executive Director and Chairman, purchased a total of 100,000 ordinary shares on the open market on December 8, 2025, at an average price of approximately HK$6.83 per share, using his personal funds. The total consideration amounted to around HK$683,000. Following this transaction, Dr. Pan holds an interest in 17,627,696 shares, representing 16.44% of the company's total issued share capital as of the announcement date.

Dr. Pan expressed confidence in the group's overall development prospects and potential growth. In compliance with applicable laws and regulatory requirements, he did not rule out the possibility of further increasing his stake in the company at an appropriate time.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1190151716"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1190151716\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1190151716?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-08 19:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1190151716","market":"us","top_or_hot":-1,"title":"SIRNAOMICS-B (02257) Chairman Pan Honghui Increases Holdings by 100,000 Shares","media":"Stock News","content":"<p>SIRNAOMICS-B (02257) announced that Dr. Pan Honghui, the company's Executive Director and Chairman, purchased a total of 100,000 ordinary shares on the open market on December 8, 2025, at an average price of approximately HK$6.83 per share, using his personal funds. The total consideration amounted to around HK$683,000. Following this transaction, Dr. Pan holds an interest in 17,627,696 shares, representing 16.44% of the company's total issued share capital as of the announcement date.</p>\n<p>Dr. Pan expressed confidence in the group's overall development prospects and potential growth. In compliance with applicable laws and regulatory requirements, he did not rule out the possibility of further increasing his stake in the company at an appropriate time.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SIRNAOMICS-B (02257) Chairman Pan Honghui Increases Holdings by 100,000 Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSIRNAOMICS-B (02257) Chairman Pan Honghui Increases Holdings by 100,000 Shares\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time smaller\">2025-12-08 19:14</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>SIRNAOMICS-B (02257) announced that Dr. Pan Honghui, the company's Executive Director and Chairman, purchased a total of 100,000 ordinary shares on the open market on December 8, 2025, at an average price of approximately HK$6.83 per share, using his personal funds. The total consideration amounted to around HK$683,000. Following this transaction, Dr. Pan holds an interest in 17,627,696 shares, representing 16.44% of the company's total issued share capital as of the announcement date.</p>\n<p>Dr. Pan expressed confidence in the group's overall development prospects and potential growth. In compliance with applicable laws and regulatory requirements, he did not rule out the possibility of further increasing his stake in the company at an appropriate time.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02257","symbol_name":"聖諾醫藥-B","start_time":0,"source_url":"","article_id":"1190151716","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1190151716","pubTimestamp":1765192474,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"SIRNAOMICS-B (02257) announced that Dr. Pan Honghui, the company's Executive Director and Chairman, purchased a total of 100,000 ordinary shares on the open market on December 8, 2025, at an average...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02257":"圣诺医药-B","BK1161":"生物科技"},"translate_title":"圣诺生物-B(02257)董事长潘洪辉增持10万股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02257":1},"content_text":"SIRNAOMICS-B (02257) announced that Dr. Pan Honghui, the company's Executive Director and Chairman, purchased a total of 100,000 ordinary shares on the open market on December 8, 2025, at an average price of approximately HK$6.83 per share, using his personal funds. The total consideration amounted to around HK$683,000. Following this transaction, Dr. Pan holds an interest in 17,627,696 shares, representing 16.44% of the company's total issued share capital as of the announcement date.\nDr. Pan expressed confidence in the group's overall development prospects and potential growth. In compliance with applicable laws and regulatory requirements, he did not rule out the possibility of further increasing his stake in the company at an appropriate time.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}